Literature DB >> 23138358

Cerebral protection during controlled hypoperfusion in a piglet model: comparison of moderate (25°C) versus deep (18°C) hypothermia at various flow rates using intraoperative measurements and ex vivo investigation.

Thomas Walther1, Stefan Dhein, Cris Ullmann, Katja Schneider, Thomas Bilz, Ardawan Rastan, Jens Garbade, Volkmar Falk, Fabian C Emrich, Petra Muth, Friedrich W Mohr, Martin Kostelka.   

Abstract

BACKGROUND: During surgical correction of complex cardiac anomalies, some degree of hypoperfusion may be required. The aim of this study was to evaluate the effectiveness and safety of controlled cerebral hypoperfusion at moderate (25°C) versus deep (18°C) hypothermia.
METHODS: In this study, 56 female piglets (9.4 ± 0.8 kg, 3-4 weeks old) received cardiopulmonary bypass (CPB) at 25, 50, or 100% of the standard flow rate for 60 minutes of cardioplegic cardiac arrest. Body temperature was kept at 18, 25, and 37°C. Routine hemodynamic and functional parameters were measured online until 4 hours of reperfusion. Immunohistology was used to quantify heat shock protein 70 (HSP70) and nitrotyrosine (NO-Tyr) levels in the hippocampus; high-performance liquid chromatography was used to quantify jugular venous blood malondialdehyde (MDA) levels.
RESULTS: Reduced CPB flow led to significant reduction of mean arterial pressure by 79%, reduction of jugular venous oxygen saturation (SvO2) by 47%, reduction of carotid blood flow by 92%, and increase of serum lactate by 350%. All these changes were significantly enhanced in the 37°C versus the 25 and the 18°C groups. Regional oxygen saturation (rSO2) was significantly reduced in the 37°C low flow groups. HSP70, NO-Tyr, and MDA were increased in the 25 and 50% flow groups (p < 0.05). There was a significant correlation between rSO2 and SvO2 (r = 0.61) and between SvO2 and HSP70 (r = - 0.72).
CONCLUSIONS: Reduction in global blood flow during CPB leads to comparable biochemical changes in the hippocampus at 25 and 18°C. Regional oxygenation saturation, SvO2, and HSP70 are important parameters to evaluate the efficacy of further anti-ischemic therapies during surgical corrections. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138358     DOI: 10.1055/s-0032-1324710

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  4 in total

1.  Effectiveness of Mild to Moderate Hypothermic Cardiopulmonary Bypass on Early Clinical Outcomes.

Authors:  Adnan Haider; Irfan Azmatullah Khwaja; Abdul Basit Qureshi; Imran Khan; Khalid Abdul Majeed; Muhammad Shahbaz Yousaf; Hafsa Zaneb; Abdul Rehman; Imtiaz Rabbani; Sajid Khan Tahir; Habib Rehman
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-09

2.  Non-invasive optical neuromonitoring of the temperature-dependence of cerebral oxygen metabolism during deep hypothermic cardiopulmonary bypass in neonatal swine.

Authors:  Tiffany S Ko; Constantine D Mavroudis; Wesley B Baker; Vincent C Morano; Kobina Mensah-Brown; Timothy W Boorady; Alexander L Schmidt; Jennifer M Lynch; David R Busch; Javier Gentile; George Bratinov; Yuxi Lin; Sejin Jeong; Richard W Melchior; Tami M Rosenthal; Brandon C Shade; Kellie L Schiavo; Rui Xiao; J William Gaynor; Arjun G Yodh; Todd J Kilbaugh; Daniel J Licht
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-30       Impact factor: 6.200

Review 3.  Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Aida Salameh; Stefan Dhein; Ingo Dähnert; Norbert Klein
Journal:  Int J Mol Sci       Date:  2016-11-21       Impact factor: 5.923

4.  Effect of Shenmai injection on cognitive function after cardiopulmonary bypass in cardiac surgical patients: a randomized controlled trial.

Authors:  Lei Chen; Liangrong Wang; Qian Zhuo; Qiong Zhang; Feifei Chen; Liling Li; Lina Lin
Journal:  BMC Anesthesiol       Date:  2018-10-11       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.